BTK inhibitors have been noted as treatment drugs for these diseases, exhibiting an outstandingly effective therapeutic effect that is increased through BTK inhibition in an experimental animal model for autoimmune disease or B-cell malignancy [5]. Here, BTK is linked to autoimmune disease.